- Declared quarterly distribution of $0.4714 per
unit; 37th consecutive quarterly distribution
Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership")
today reported net income attributable to the Partnership in the
third quarter of 2023 of $13.2 million, or $0.37 per limited
partner unit, compared to third quarter 2022 net income of $14.8
million. The reduction in Partnership net income in the third
quarter of 2023 compared to the third quarter of 2022 was the
result of higher interest expense attributable to higher interest
rates on floating rate debt. Cash flows from operating activities
in the third quarter of 2023 were $100.9 million, a decrease of
$14.6 million compared to third quarter 2022 cash flows from
operating activities of $115.5 million. The decrease was primarily
due to lower Partnership net income and less favorable working
capital changes. For the three months ended September 30, 2023, MLP
distributable cash flow was $13.6 million, a decrease of $3.1
million compared to third quarter 2022 MLP distributable cash flow.
The decrease in MLP distributable cash flow was attributable to
higher interest expense and changes in the timing of maintenance
capital expenditures.
Third quarter 2023 net income attributable to the Partnership of
$13.2 million increased by $1.3 million compared to second quarter
2023 net income of $11.9 million due to increased sales volume as a
result of the completion of the Calvert City turnaround in the
second quarter of 2023. Third quarter 2023 cash flows from
operating activities of $100.9 million increased by $2.4 million
compared to second quarter 2023 cash flows from operating
activities of $98.5 million due to higher net income at OpCo. Third
quarter 2023 MLP distributable cash flow of $13.6 million decreased
by $1.4 million compared to second quarter 2023 MLP distributable
cash flow of $15.0 million, primarily due to higher maintenance
capital expenditures, which are weighted towards the second half of
the year in 2023.
"We were pleased with the Partnership's performance in the third
quarter of 2023, with net income, EBITDA and cash flow from
operations all increasing from the second quarter. While
distributable cash flow was sequentially lower due to the timing of
maintenance capital spending, our underlying financial results and
cash flows remain stable and predictable, supported by our sales
agreement with Westlake that delivers a fixed margin on 95% of our
production," said Albert Chao, President and Chief Executive
Officer. "While the Partnership's coverage ratio has declined due
to turnaround activity, we expect it to recover in future periods
after turnaround activity is complete."
On October 31, 2023, the Partnership announced that the Board of
Directors of Westlake Chemical Partners GP LLC had approved a
quarterly distribution for the third quarter of 2023 of $0.4714 per
unit to be payable on November 27, 2023 to unitholders of record as
of November 10, 2023, representing the 37th consecutive quarterly
distribution to our unitholders. MLP distributable cash flow
provided trailing twelve-month coverage of 1.00x the declared
distributions for the third quarter of 2023.
OpCo's Ethylene Sales Agreement with Westlake is designed to
provide for stable and predictable cash flows. The agreement
provides that 95% of OpCo's ethylene production is sold to Westlake
for a cash margin of $0.10 per pound, net of operating costs,
maintenance capital expenditures and reserves for future turnaround
expenditures.
The statements in this release and the related teleconference
relating to matters that are not historical facts, such as those
with respect to the ability to deliver value, returns, predictable
cash flows and distributions to unitholders, demand for ethylene
and expected margins and production volumes, contracted volumes,
the expectation that strong distributions will continue, future
coverage ratios, and the nature of the sales agreement with
Westlake, are forward-looking statements. These forward-looking
statements are subject to significant risks and uncertainties.
Actual results could differ materially, based on factors including,
but not limited to: pandemic infectious diseases and the response
thereto; operating difficulties; the volume of ethylene that we are
able to sell; the price at which we are able to sell ethylene;
changes in the price and availability of feedstocks; changes in
prevailing economic conditions, including inflation, interest rates
and possible recession; actions and commitments of Westlake
Corporation; actions of third parties; inclement or hazardous
weather conditions, including flooding, and the physical impacts of
climate change; environmental hazards; changes in laws and
regulations (or the interpretation thereof); inability to acquire
or maintain necessary permits; inability to obtain necessary
production equipment or replacement parts; technical difficulties
or failures; labor disputes; difficulty collecting receivables;
inability of our customers to take delivery; fires, explosions or
other industrial accidents; availability of insurance; our ability
to borrow funds and access capital markets; and other
uncertainties. For more detailed information about the factors that
could cause actual results to differ materially, please refer to
the Partnership's Annual Report on Form 10-K for the year ended
December 31, 2022, which was filed with the SEC in March 2023, and
Quarterly Report on Form 10-Q for the quarter ended June 30, 2023,
which was filed with the SEC in August 2023.
This release is intended to be a qualified notice under Treasury
Regulation Section 1.1446-4(b). Brokers and nominees should treat
one hundred percent (100.0%) of the Partnership's distributions to
non-U.S. investors as being attributable to income that is
effectively connected with a United States trade or business.
Accordingly, the Partnership's distributions to non-U.S. investors
are subject to federal income tax withholding at the highest
applicable effective tax rate.
Use of Non-GAAP Financial Measures
This release makes reference to certain "non-GAAP" financial
measures, such as MLP distributable cash flow and EBITDA. A
non-GAAP financial measure is generally defined by the Securities
and Exchange Commission ("SEC") as a numerical measure of a
registrant's historical or future financial performance, financial
position or cash flows that (1) excludes amounts, or is subject to
adjustments that have the effect of excluding amounts, that are
included in the most directly comparable measure calculated and
presented in accordance with U.S. generally accepted accounting
principles ("U.S. GAAP") in the statement of income, balance sheet
or statement of cash flows (or equivalent statements) of the
registrant; or (2) includes amounts, or is subject to adjustments
that have the effect of including amounts, that are excluded from
the most directly comparable measure so calculated and presented.
We report our financial results in accordance with U.S. GAAP, but
believe that certain non-GAAP financial measures, such as MLP
distributable cash flow and EBITDA, provide useful supplemental
information to investors regarding the underlying business trends
and performance of our ongoing operations and are useful for
period-over-period comparisons of such operations. These non-GAAP
financial measures should be considered as a supplement to, and not
as a substitute for, or superior to, the financial measures
prepared in accordance with U.S. GAAP. We define MLP distributable
cash flow as distributable cash flow less distributable cash flow
attributable to Westlake Corporation's noncontrolling interest in
OpCo and distributions attributable to the incentive distribution
rights holder. MLP distributable cash flow does not reflect changes
in working capital balances. We define EBITDA as net income before
interest expense, income taxes, depreciation and amortization. MLP
distributable cash flow and EBITDA are non-GAAP supplemental
financial measures that management and external users of our
consolidated financial statements, such as industry analysts,
investors, lenders and rating agencies, may use to assess our
operating performance as compared to other publicly traded
partnerships, our ability to incur and service debt and fund
capital expenditures and the viability of acquisitions and other
capital expenditure projects and the returns on investment of
various investment opportunities. Reconciliations of MLP
distributable cash flow to net income and to net cash provided by
operating activities and of EBITDA to net income, income from
operations and net cash provided by operating activities can be
found in the financial schedules at the end of this press
release.
Westlake Chemical Partners LP
Westlake Chemical Partners is a limited partnership formed by
Westlake Corporation to operate, acquire and develop ethylene
production facilities and other qualified assets. Headquartered in
Houston, the Partnership owns a 22.8% interest in Westlake Chemical
OpCo LP. Westlake Chemical OpCo LP's assets consist of three
ethylene production facilities in Calvert City, Kentucky, and Lake
Charles, Louisiana and an ethylene pipeline. For more information
about Westlake Chemical Partners LP, please visit
http://www.wlkpartners.com.
Westlake Chemical Partners LP Conference Call Information:
A conference call to discuss Westlake Chemical Partners' third
quarter 2023 results will be held Thursday, November 2, 2023 at
1:00 PM Eastern Time (12:00 PM Central Time). To access the
conference call, it is necessary to pre-register at
https://register.vevent.com/register/BIba82e736e2dc4c7795c84d6a93ba20f8.
Once registered, you will receive a phone number and unique PIN
number.
A replay of the conference call will be available beginning two
hours after its conclusion. The conference call and replay will be
available via webcast at
https://edge.media-server.com/mmc/p/4yt2s6sr.
WESTLAKE CHEMICAL PARTNERS LP
("WESTLAKE PARTNERS")
CONSOLIDATED STATEMENTS OF
OPERATIONS
(Unaudited)
Three Months Ended September
30,
Nine Months Ended September
30,
2023
2022
2023
2022
(In thousands of dollars,
except per unit data)
Revenue
Net sales—Westlake Corporation
("Westlake")
$
289,303
$
364,273
$
771,349
$
1,020,042
Net co-products, ethylene and other
sales—third parties
32,361
50,850
122,169
206,266
Total net sales
321,664
415,123
893,518
1,226,308
Cost of sales
228,683
324,629
606,742
947,073
Gross profit
92,981
90,494
286,776
279,235
Selling, general and administrative
expenses
6,741
8,678
21,884
26,824
Income from operations
86,240
81,816
264,892
252,411
Other income (expense)
Interest expense—Westlake
(6,437
)
(3,645
)
(19,869
)
(8,703
)
Other income, net
1,272
618
3,153
683
Income before income taxes
81,075
78,789
248,176
244,391
Provision for income taxes
222
484
607
822
Net income
80,853
78,305
247,569
243,569
Less: Net income attributable to
noncontrolling interest in Westlake Chemical OpCo LP ("OpCo")
67,647
63,548
207,585
196,180
Net income attributable to Westlake
Partners
$
13,206
$
14,757
$
39,984
$
47,389
Net income per limited partner unit
attributable to Westlake Partners (basic and diluted)
Common units
$
0.37
$
0.42
$
1.14
$
1.35
Distributions declared per unit
$
0.4714
$
0.4714
$
1.4142
$
1.4142
MLP distributable cash flow
$
13,620
$
16,734
$
46,156
$
55,609
Distributions declared
Limited partner units—publicly and
privately held
$
9,949
$
9,947
$
29,841
$
29,828
Limited partner units—Westlake
6,658
6,657
19,973
19,971
Total distributions declared
$
16,607
$
16,604
$
49,814
$
49,799
EBITDA
$
115,738
$
111,825
$
349,947
$
344,776
WESTLAKE CHEMICAL PARTNERS
LP
CONDENSED CONSOLIDATED BALANCE
SHEETS
(Unaudited)
September 30,
2023
December 31,
2022
(In thousands of
dollars)
ASSETS
Current assets
Cash and cash equivalents
$
65,869
$
64,782
Receivable under the Investment Management
Agreement—Westlake
84,358
64,996
Accounts receivable, net—Westlake
54,625
90,965
Accounts receivable, net—third parties
21,626
20,030
Inventories
4,394
4,715
Prepaid expenses and other current
assets
599
305
Total current assets
231,471
245,793
Property, plant and equipment, net
959,114
990,213
Other assets, net
150,925
135,973
Total assets
$
1,341,510
$
1,371,979
LIABILITIES AND EQUITY
Current liabilities (accounts payable and
accrued and other liabilities)
$
75,600
$
66,941
Long-term debt payable to Westlake
399,674
399,674
Other liabilities
4,964
1,656
Total liabilities
480,238
468,271
Common unitholders—publicly and privately
held
474,895
480,643
Common unitholder—Westlake
49,919
53,859
General partner—Westlake
(242,572
)
(242,572
)
Total Westlake Partners partners'
capital
282,242
291,930
Noncontrolling interest in OpCo
579,030
611,778
Total equity
861,272
903,708
Total liabilities and equity
$
1,341,510
$
1,371,979
WESTLAKE CHEMICAL PARTNERS
LP
CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS
(Unaudited)
Nine Months Ended September
30,
2023
2022
(In thousands of
dollars)
Cash flows from operating
activities
Net income
$
247,569
$
243,569
Adjustments to reconcile net income to net
cash provided by operating activities
Depreciation and amortization
81,902
91,682
Net loss on disposition and other
4,352
8,788
Other balance sheet changes
10,505
(2,877
)
Net cash provided by operating
activities
344,328
341,162
Cash flows from investing
activities
Additions to property, plant and
equipment
(33,979
)
(45,458
)
Investments with Westlake under the
Investment Management Agreement
(164,116
)
(276,000
)
Maturities of investments with Westlake
under the Investment Management Agreement
145,000
247,000
Net cash used for investing activities
(53,095
)
(74,458
)
Cash flows from financing
activities
Proceeds from debt payable to Westlake
155,250
—
Repayment of debt payable to Westlake
(155,250
)
—
Distributions to noncontrolling interest
retained in OpCo by Westlake
(240,333
)
(214,486
)
Distributions to unitholders
(49,813
)
(49,807
)
Net cash used for financing activities
(290,146
)
(264,293
)
Net increase in cash and cash
equivalents
1,087
2,411
Cash and cash equivalents at beginning of
period
64,782
17,057
Cash and cash equivalents at end of
period
$
65,869
$
19,468
WESTLAKE CHEMICAL PARTNERS
LP
RECONCILIATION OF MLP
DISTRIBUTABLE CASH FLOW TO NET INCOME
AND NET CASH PROVIDED BY
OPERATING ACTIVITIES
(Unaudited)
Three Months Ended June
30,
Three Months Ended September
30,
Nine Months Ended September
30,
2023
2023
2022
2023
2022
(In thousands of
dollars)
Net cash provided by operating
activities
$
98,543
$
100,925
$
115,495
$
344,328
$
341,162
Changes in operating assets and
liabilities and other
(23,279
)
(20,072
)
(37,190
)
(96,759
)
(97,593
)
Net income
75,264
80,853
78,305
247,569
243,569
Add:
Depreciation, amortization and disposition
of property, plant and equipment
27,095
32,242
30,349
86,340
96,070
Less:
Contribution to turnaround reserves
(6,967
)
(7,565
)
(7,323
)
(21,838
)
(21,811
)
Maintenance capital expenditures
(6,521
)
(22,862
)
(14,348
)
(37,407
)
(38,172
)
Distributable cash flow attributable to
noncontrolling interest in OpCo
(73,886
)
(69,048
)
(70,249
)
(228,508
)
(224,047
)
MLP distributable cash flow
$
14,985
$
13,620
$
16,734
$
46,156
$
55,609
WESTLAKE CHEMICAL PARTNERS
LP
RECONCILIATION OF EBITDA TO
NET INCOME, INCOME FROM OPERATIONS AND NET CASH
PROVIDED BY OPERATING
ACTIVITIES
(Unaudited)
Three Months Ended June
30,
Three Months Ended September
30,
Nine Months Ended September
30,
2023
2023
2022
2023
2022
(In thousands of
dollars)
Net cash provided by operating
activities
$
98,543
$
100,925
$
115,495
$
344,328
$
341,162
Changes in operating assets and
liabilities and other
(23,279
)
(20,072
)
(37,190
)
(96,759
)
(97,593
)
Net income
75,264
80,853
78,305
247,569
243,569
Less:
Other income, net
1,061
1,272
618
3,153
683
Interest expense—Westlake
(6,117
)
(6,437
)
(3,645
)
(19,869
)
(8,703
)
Provision for income taxes
(173
)
(222
)
(484
)
(607
)
(822
)
Income from operations
80,493
86,240
81,816
264,892
252,411
Add:
Depreciation and amortization
27,040
28,226
29,391
81,902
91,682
Other income, net
1,061
1,272
618
3,153
683
EBITDA
$
108,594
$
115,738
$
111,825
$
349,947
$
344,776
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231102631383/en/
Contact—(713) 585-2900 Investors—Steve Bender Media—L. Benjamin
Ederington
Westlake Chemical Partners (NYSE:WLKP)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Westlake Chemical Partners (NYSE:WLKP)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024